Colin A. Campbell

Internal Medicine
289 White Horse Pike Ste 101
Atco, NJ 08004

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

The type 2 CCK/gastrin receptor antagonist YF476 acutely prevents NSAID-induced gastric ulceration while increasing iNOS expression.

The type 2 CCK/gastrin receptor antagonist YF476 acutely prevents NSAID-induced gastric ulceration while increasing iNOS expression.

Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: September 18, 2012
Showing 1-1 of 1

Last Updated: 09/26/2026